MGMT promoter methylation status in clival chordoma (Q33275237)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	MGMT promoter methylation status in clival chordoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

MGMT promoter methylation status in clival chordoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

Diego Mazzatenta

object named as

Diego Mazzatenta

3

0 references

object named as

Luca Morandi

2

0 references

Gianluca Marucci

object named as

Gianluca Marucci

1

0 references

Maria P. Foschini

object named as

Maria Pia Foschini

6

0 references

author name string

Giorgio Frank

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Ernesto Pasquini

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

26 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

271-276

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Chordoma: current concepts, management, and future directions

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Molecular characterization of putative chordoma cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Chordoma: the nonsarcoma primary bone tumor

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Chordoma characterization of significant changes of the DNA methylation pattern

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Frequent IDH1/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Current therapeutic options and novel molecular markers in skull base chordomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Imatinib mesylate in chordoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Phase II study of imatinib in advanced chordoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1445-Y

21 January 2018

Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/24771251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24771251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endoscopic transnasal transsphenoidal approach for the treatment of cranial base chordomas and chondrosarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24771251

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-014-1445-Y

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33275237&oldid=2195189707"